Cheng Xiang Dai

Corporate Officer/Principal en CELLULAR BIOMEDICINE GROUP, INC. .

Health Technology

Consumer Services

Perfil

Cheng Xiang Dai currently works at AbelZeta Pharma, Inc., as General Manager-Stem Cell Business Unit.
Dr. Dai also formerly worked at Venturepharma, Inc., as Medical Director.
Dr. Dai received his graduate degree from Zhengzhou University.

Cargos activos de Cheng Xiang Dai

Empresas	Cargo	Inicio
CELLULAR BIOMEDICINE GROUP, INC.	Corporate Officer/Principal	11/07/2013

Todos los cargos activos de Cheng Xiang Dai

Antiguos cargos conocidos de Cheng Xiang Dai.

Empresas	Cargo	Fin
Venturepharma, Inc. Venturepharma, Inc. Pharmaceuticals: MajorHealth Technology Venturepharma, Inc. manufactures pharmaceutical products. It offers VP discovery, API development and outsourcing, biopharmaceuticals discovery, RX and OTC. The firm provides products for oncology, CNS, dermnova, diabetes, cardiovascular, respiration and vaccine. The company was founded in 1998 and is headquartered in Haidian, China.	Chief Tech/Sci/R&D Officer	-

Ver el detalle de la experiencia de Cheng Xiang Dai.

Formación de Cheng Xiang Dai.

Zhengzhou University

Graduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Cheng Xiang Dai.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
Venturepharma, Inc. Venturepharma, Inc. Pharmaceuticals: MajorHealth Technology Venturepharma, Inc. manufactures pharmaceutical products. It offers VP discovery, API development and outsourcing, biopharmaceuticals discovery, RX and OTC. The firm provides products for oncology, CNS, dermnova, diabetes, cardiovascular, respiration and vaccine. The company was founded in 1998 and is headquartered in Haidian, China.	Health Technology
AbelZeta Pharma, Inc. AbelZeta Pharma, Inc. BiotechnologyHealth Technology Cellular Biomedicine Group, Inc. is a holding company, which engages in the development of new treatments for cancerous and degenerative diseases utilizing proprietary cell-based technologies. It specializes in immune cell therapy. The company was founded in 2009 and is headquartered in Rockville, MD.	Health Technology